Immatics presenting at HW Cell Therapy Analytical Development Summit
Dec 16, 2020 from 3:30 PM to 5:00 PM EST
Meet us virtually at the Cell Therapy Analytical Development Summit and discuss how to advance analytical tools to ensure the quality, safety and efficacy of the next generation of Cell Therapies. Learn more about how Immatics is selecting healthy donors for Allogeneic T Cell Therapy.
Wednesday, December 16, 3.30pm EST | 12.30pm PST
Session Developing Novel and Efficient Analytical Techniques for Development of Next Generation Cell Therapy Products
Presentation: Donor Selection for Allogeneic T Cell Therapy
• Regulatory/ legal/ ethical aspects of donor selection for an allogeneic T cell program
• Characterization of starting material and donor characteristics impacting the quality of immune cells
• Defining donor suitability based on evaluation in manufacturing process
Presenter: Mamta Kalra , Director CMC, Immatics
We are looking forward to e-meeting you!
Learn more about the Cell Therapy Analytical Development Summit here.